Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Quick Stats
Jan 30, 202653.8
AI Score
HOLD0.97
Volume Ratio
Mar 04, 2026
Next Earnings
13
+ve Days (30d)
15
-ve Days (30d)
FATE Stock Summary
Last updated Jan 30, 2026
FATE is currently trading at $1.19, positioned above its 200-day moving average of $1.16, indicating a long-term uptrend. The stock has a 52-week range of $0.66105 to $1.9399.
Technical Analysis: The 50-day moving average stands at $1.08, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.282, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.144, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates FATE at 53.8/100 with a HOLD recommendation.
FATE (Fate Therapeutics, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 54.282 |
| CMF (20) | 0.144 |
| ROC (10) | 13.333 |
| ADX (14) | 29.258 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.042 |
| AROONOSC (14) | 71.429 |
| WILLAMS %R (14) | -43.333 |
| MFI (14) | 55.434 |
FATE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
FATE Price vs Max Options Open Interest
FATE Max Change In Options Open Interest
FATE Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FATE Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FATE Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FATE Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Fate Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
FATE Moving Averages Analysis
Fate Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Fate Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
FATE (Fate Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.2 |
| 20 | 1.12 |
| 30 | 1.09 |
| 50 | 1.08 |
| 100 | 1.15 |
| 200 | 1.16 |
FATE Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 139.6 million |
| Earnings/Share ($) | -1.33 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.1489 |
| EPS Estimate Next Year ($) | -1.1567 |
| WallStreet Target Price ($) | 4.9444 |
| Most Recent Quarter |